Analystreport

Supernus Pharmaceuticals (NASDAQ:SUPN) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.

Supernus Pharmaceuticals, Inc.  (SUPN) 
Last supernus pharmaceuticals, inc. earnings: 2/25 04:40 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.supernus.com